Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04284787
What this trial is testing

BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05751928
What this trial is testing

Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma (Skin)
Biocad 411
Not applicableStudy completedNCT07236931
What this trial is testing

Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells

Who this might be right for
AML (Acute Myeloid Leukemia)
Donghua Zhang 103
Testing effectiveness (Phase 2)WithdrawnNCT03733067
What this trial is testing

Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency

Who this might be right for
CTLA4 HaploinsufficencyChronic Cytopenia
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Looking for participantsNCT07476326
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Who this might be right for
Melanoma
Biocon Biologics UK PLC 120
Testing effectiveness (Phase 2)Ended earlyNCT03362619
What this trial is testing

Engineered Immune Effectors Against Cervical Cancer

Who this might be right for
Cervical Cancer
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00058617
What this trial is testing

Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL

Who this might be right for
Epstein-Barr Virus-Related Hodgkin LymphomaEpstein-Barr Virus-Related Non-Hodgkin LymphomaEBV Positive Plasma Cell Neoplasm
Baylor College of Medicine 13
Early research (Phase 1)Study completedNCT00001818
What this trial is testing

Combination Drug Treatment of Pediatric HIV Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT02157792
What this trial is testing

M6620 First in Human Study

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 200
Testing effectiveness (Phase 2)Study completedNCT00002609
What this trial is testing

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 40
Not applicableWithdrawnNCT00402935
What this trial is testing

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Who this might be right for
LeukemiaLong-term Effects Secondary to Cancer Therapy in AdultsLong-term Effects Secondary to Cancer Therapy in Children+5 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT02226289
What this trial is testing

Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment

Who this might be right for
NeoplasmColorectal CancerMetastatic Neoplasm
Sixth Affiliated Hospital, Sun Yat-sen University 46
Not applicableEnded earlyNCT00000824
What this trial is testing

Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT01447056
What this trial is testing

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoproliferative Disorder+3 more
Baylor College of Medicine 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04414540
What this trial is testing

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Trisha Wise-Draper 21
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Not applicableUnknownNCT04460755
What this trial is testing

Tooth Whitening Evaluation With Cytotoxic and Genotoxic Effect of Commercial Whitening Toothpastes on Oral Mucosal Cells

Who this might be right for
Teeth Whitening
University of Zagreb 210
Early research (Phase 1)Study completedNCT01970540
What this trial is testing

Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors

Who this might be right for
Endometrial AdenocarcinomasNeuroendocrine TumorsSmall-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy
PharmaMar 122
Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Next Page